MARIANNE MILOS: Open Payments
NPI 1215973623 · NEW PORT RICHEY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 14 payments from 9 companies in 2025. Trend: 2023 $30 · 2024 $69 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 3 | $74 |
| Phathom Pharmaceuticals, Inc. | 3 | $65 |
| Intercept Pharmaceuticals, Inc. | 2 | $31 |
| Celltrion USA Inc. | 1 | $30 |
| ABBVIE INC. | 1 | $27 |
| Novo Nordisk Inc | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Exact Sciences Corporation | 1 | $16 |
Products named: REZDIFFRA, VOQUEZNA, OCALIVA, VEGZELMA, CREON, Wegovy, XIFAXAN, EOHILIA.
Industry payments across FL — which companies pay providers there.
